Related Experiment Video
Updated: Aug 8, 2026

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Interaction of xenobiotics with myocardial signal transduction pathways
Russell B Melchert1, Jacob Joseph, Richard H Kennedy
1University of Arkansas for Medical Sciences, Department of Pharmaceutical Sciences, Little Rock, AR 72205, USA. RussellB@uams.edu
Abstract:
Although the understanding of how toxicants alter cardiac ion-channel function has matured rapidly over the past 20-30 yr, little is known about how xenobiotics may alter the signaling pathways of cardiac myocyte growth and death. Signaling molecules and pathways responsible for the growth of cardiac myocytes include the mitogen-activated protein kinases (MAPKs), janus kinase-signal transducer and activator of transcription (JAK-STATs), nuclear receptor signaling, calcineurin, and the mobilization of free calcium. Signaling molecules and pathways responsible for programmed cardiac myocyte death include the death receptors, mitochondrial proteins, p53 tumor suppressor protein, ceramide signaling, and caspases. Overlap or "crosstalk" between the various growth and death pathways in the myocardium is evident, and these pathways likely exist in a delicate balance where, for example, slight reductions in growth signaling may favor pathways leading to cardiac myocyte apoptosis. Several classical cardiotoxicants are now known to alter signaling pathways in cardiac myocytes; however, the significance of these effects is not entirely clear. Furthermore, xenobiotics that alter the interstitium or extracellular matrix, or both, may significantly alter signaling pathways in cardiac myocytes. The goal of this review is to summarize current findings regarding the interaction of xenobiotics with myocardial signal transduction pathways in the hope of stimulating new insights and highlighting important areas for future research.
Insights
Xenobiotics, or foreign compounds, can disrupt cardiac myocyte growth and death signaling pathways. Understanding these interactions is crucial for identifying new research directions in cardiotoxicity.
Area of Science:
- Cardiovascular Toxicology
- Molecular Cardiology
- Pharmacology
Background:
- While cardiac ion channel function alterations by toxicants are well-studied, the impact of xenobiotics on cardiac myocyte growth and death signaling remains largely unknown.
- Cardiac myocyte growth involves pathways like MAPKs, JAK-STATs, and calcium signaling, while death pathways include caspases and p53.
Purpose of the Study:
- To review current knowledge on how xenobiotics interact with myocardial signal transduction pathways.
- To highlight areas for future research in xenobiotic-induced cardiotoxicity.
Main Methods:
- Literature review of studies investigating xenobiotic effects on cardiac signaling.
- Analysis of known signaling pathways involved in cardiac myocyte growth and apoptosis.
Main Results:
- Several cardiotoxicants are known to affect cardiac myocyte signaling pathways, but the clinical significance is unclear.
- Xenobiotics can also impact cardiac signaling indirectly by altering the cardiac interstitium or extracellular matrix.
Conclusions:
- There is significant crosstalk between cardiac growth and death pathways, suggesting a delicate balance that can be disrupted by xenobiotics.
- Further research is needed to elucidate the precise mechanisms and consequences of xenobiotic interactions with myocardial signal transduction.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Pathophysiology of Cardiac Performance
Heart Failure Drugs: Inotropic Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction

